Mesoporous polydopamine-based nanodrug delivery systems for tumor immunotherapy
Nanoscale Horizons · 2026 · 11 (11) · 2700-2722
DOI: 10.1039/d6nh00175k ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nanoscale Horizons, 2026. Verfasst von Yulin Wen und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, The Affiliated Hospital, Southwest Medical University, Luzhou, China. hyl3160131@126.com. Hauptthemen laut MEDLINE: Polymers, Indoles, Immunotherapy, Neoplasms. Die Arbeit nennt 150 Literaturangaben. Gefördert von: Sichuan Provincial Science and Technology Support Program.
Abstract (Originalsprache)
Mesoporous polydopamine-based nanodrug delivery systems integrate multimodal therapeutic strategies, immune activation, and tumor microenvironment remodeling for enhanced cancer immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, The Affiliated Hospital, Southwest Medical University, Luzhou, China. hyl3160131@126.com.
- Department of Clinical Pharmacy, School of Pharmacy, Southwest Medical University, Luzhou, China.
- Department of Urology, The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, China.
Förderung
- Sichuan Provincial Science and Technology Support Program
Zitieren
APA
Wen, Y., Li, R., Ke, J., Wang, M., Wu, S., Feng, B., Xie, L., Jing, P., Tao, C., Huang, Y., & Zhou, M. (2026). Mesoporous polydopamine-based nanodrug delivery systems for tumor immunotherapy. Nanoscale Horizons, 11(11), 2700-2722. https://doi.org/10.1039/d6nh00175k
Vancouver
Wen Y, Li R, Ke J, Wang M, Wu S, Feng B, et al. Mesoporous polydopamine-based nanodrug delivery systems for tumor immunotherapy. Nanoscale Horizons. 2026;11(11):2700-2722. doi:10.1039/d6nh00175k
BibTeX
@article{Wen2026,
author = {Wen, Yulin and Li, Ruixiao and Ke, Jingwei and Wang, Meiyi and Wu, Siqiong and Feng, Bimin and Xie, Lei and Jing, Pei and Tao, Chao and Huang, Yilan and Zhou, Meiling},
title = {Mesoporous polydopamine-based nanodrug delivery systems for tumor immunotherapy},
journal = {Nanoscale Horizons},
year = {2026},
volume = {11},
number = {11},
pages = {2700--2722},
doi = {10.1039/d6nh00175k}
}
EUVIMED